ZNF700 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.1379347705024E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.11737352282671E-12 |
Normal-vs-Stage2 |
2.994900E-04 |
Normal-vs-Stage3 |
2.27460000001845E-06 |
Normal-vs-Stage4 |
6.12099999999227E-05 |
Stage1-vs-Stage2 |
9.908600E-01 |
Stage1-vs-Stage3 |
6.659600E-01 |
Stage1-vs-Stage4 |
9.015200E-01 |
Stage2-vs-Stage3 |
7.754200E-01 |
Stage2-vs-Stage4 |
9.270000E-01 |
Stage3-vs-Stage4 |
8.378800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.21418455687217E-12 |
Normal-vs-AfricanAmerican |
5.02649999956084E-07 |
Normal-vs-Asian |
1.139570E-02 |
Caucasian-vs-AfricanAmerican |
3.767600E-01 |
Caucasian-vs-Asian |
4.411900E-02 |
AfricanAmerican-vs-Asian |
4.646300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.30849808555445E-11 |
Normal-vs-Female |
1.75760517251433E-11 |
Male-vs-Female |
4.182600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.841700E-02 |
Normal-vs-Age(41-60Yrs) |
4.19075885105258E-12 |
Normal-vs-Age(61-80Yrs) |
1.01949999553597E-08 |
Normal-vs-Age(81-100Yrs) |
2.257600E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.896000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.839400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.373800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.035200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.595000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.813000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.096700E-03 |
Normal-vs-Grade 2 |
1.49139589566971E-11 |
Normal-vs-Grade 3 |
2.14469997317224E-10 |
Normal-vs-Grade 4 |
7.782300E-03 |
Grade 1-vs-Grade 2 |
5.326000E-01 |
Grade 1-vs-Grade 3 |
4.457200E-01 |
Grade 1-vs-Grade 4 |
1.212350E-01 |
Grade 2-vs-Grade 3 |
7.351400E-01 |
Grade 2-vs-Grade 4 |
5.185900E-02 |
Grade 3-vs-Grade 4 |
8.537900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.71318514929908E-12 |
Normal-vs-ccB subtype |
1.73556999999436E-05 |
ccA subtype-vs-ccB subtype |
2.019900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.37050387599902E-11 |
Normal-vs-N1 |
1.028820E-01 |
N0-vs-N1 |
9.762400E-01 |
|
|